Canakinumab is an effective therapeutic drug for various autoimmune diseases, Still's disease, and gout. Its price, purchasing channels, and storage methods have always been the focus of patients' attention.
What is the latest price of canakinumab in 2025?
The latest price of canakinumab in 2025 is affected by many factors. Moreover, the drug has not been launched in China and is not included in China's medical insurance list, so patients need to bear all the treatment costs on their own.
Price Overview
According to the latest market research, the price of the Swiss Novartis original canakinumab (specification: 150mg/mL) in the international market is approximately $1,331 per box. The above price is for reference only, and the specific price may vary due to factors such as region, sales channel, and promotional activities.
Analysis of Price Trend
With the continuous advancement of biopharmaceutical technology and the intensification of market competition, the price of canakinumab has shown certain fluctuations. From the overall trend, as pharmaceutical costs decrease and market demand increases, the price of canakinumab is expected to remain stable or decrease slightly. Different countries and regions may further reduce the medication burden on patients through medical insurance policies, negotiated procurement, and other methods.
What are the purchasing channels for canakinumab?
Since canakinumab has not been launched in China, patients can consider purchasing it through other channels.
Officially Authorized Channels
The preferred channel for purchasing canakinumab is through officially authorized pharmacies or medical institutions. The drugs provided by these channels have undergone strict quality control, ensuring legal sources and reliable quality. Patients can inquire about officially authorized channels through the official website of the pharmaceutical company or customer service hotline, and choose a suitable purchasing method according to their own needs.
Overseas Purchasing Channels
These channels usually include regular overseas pharmacies, medical institutions, or pharmaceutical e-commerce platforms. When choosing overseas purchasing, patients should carefully check the drug information, seller qualifications, transportation methods, etc., to confirm the safety of the purchased drugs.
How to store canakinumab after purchase?
The storage conditions of canakinumab can directly affect its efficacy and safety, so patients need to strictly abide by the storage requirements when storing this drug.
Storage Conditions
According to the drug instruction, unopened canakinumab should be stored in a refrigerated condition at 2-8℃ away from light. Avoid exposing the drug to high temperature, humidity, or direct sunlight, so as not to affect the stability of the drug. After purchasing canakinumab, patients should carefully read the drug instruction to understand the correct storage method.
It is also reminded that patients must follow the doctor's advice and the drug instruction when purchasing and using canakinumab to use the drug safely and reasonably.
